Adaptive Phage Therapeutics

Recent Finacing

Series B I

Recent Raise

$24M

Adaptive Phage Therapeutics operates PhageBank, a curated bacteriophage library and proprietary susceptibility assay commercialized with Mayo Clinic to match phages to patient infections for clinical PJI and DFO programs.

Founded 2016

Maryland, United States

51-100

Private

aphage.com

Highlights

Focus Areas

Biotechnology

Health Care

Pharmaceutical

Therapeutics

Recent Investors

Financials

$91.8M

Total Raised

4

Funding rounds

4

Investors

Team

Upgrade to view the team

See the team members at Adaptive Phage Therapeutics.